{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:34:23Z","timestamp":1793799263322,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC240525"],"award-info":[{"award-number":["20252BAC240525"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117062","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:33:05Z","timestamp":1782891185000},"page":"117062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PCIF1-mediated m6Am modification activates USP5\/BRD4 axis to promote glycolysis-driven immunosuppression in multiple myeloma"],"prefix":"10.1016","volume":"186","author":[{"given":"Shifeng","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2026.117062_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.trecan.2024.06.002","article-title":"Targeting cancer stem cells in multiple myeloma","volume":"10","author":"Gunes","year":"2024","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2026.117062_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-med-050522-033815","article-title":"New biological therapies for multiple myeloma","volume":"75","author":"Garfall","year":"2024","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117062_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/oncolo\/oyad306","article-title":"Perspectives on the treatment of multiple myeloma","volume":"29","author":"Rafae","year":"2024","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.intimp.2026.117062_bb0030","article-title":"New therapies in multiple myeloma: benefits and limitations","volume":"135","author":"Jurczyszyn","year":"2025","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2026.117062_bb0035","article-title":"Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.intimp.2026.117062_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111430","article-title":"Metabolic disorders in multiple myeloma","volume":"22","author":"Gavriatopoulou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117062_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13258-019-00900-z","article-title":"miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis","volume":"42","author":"Wu","year":"2020","journal-title":"Genes Genomics"},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4149\/neo_2022_211102N1559","article-title":"NBR2\/miR-561-5p\/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK\/mTOR pathway to repress glycolysis","volume":"69","author":"Wang","year":"2022","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.intimp.2026.117062_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00262-025-04031-1","article-title":"USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis","volume":"74","author":"Long","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.intimp.2026.117062_bb0060","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41590-024-01923-9","article-title":"NaCl enhances CD8(+) Tcell effector functions in cancer immunotherapy","volume":"25","author":"Scirgolea","year":"2024","journal-title":"Nat. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2026.117062_bb0065","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","article-title":"H3K18 lactylation potentiates immune escape of non-small cell lung cancer","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2026.117062_bb0070","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0075","doi-asserted-by":"crossref","first-page":"2218771","DOI":"10.1080\/15592294.2023.2218771","article-title":"RNA modification m(6)Am: the role in cardiac biology","volume":"18","author":"Benak","year":"2023","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.intimp.2026.117062_bb0080","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111673","article-title":"Role of PCIF1-mediated 5\u2032-cap N6-methyladeonsine mRNA methylation in colorectal cancer and anti-PD-1 immunotherapy","volume":"42","author":"Wang","year":"2023","journal-title":"EMBO J."},{"issue":"46","key":"10.1016\/j.intimp.2026.117062_bb0085","article-title":"m6Am methyltransferase PCIF1 promotes LPP3 mediated phosphatidic acid metabolism and renal cell carcinoma progression","volume":"11","author":"Luo","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.intimp.2026.117062_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104557","article-title":"Structure and function of USP5: insight into physiological and pathophysiological roles","volume":"157","author":"Ning","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41467-025-56564-9","article-title":"USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation","volume":"16","author":"Shao","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117062_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cac2.12403","article-title":"METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"43","author":"Xia","year":"2023","journal-title":"Cancer Commun. (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.intimp.2026.117062_bb0110","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1016\/j.molcel.2024.09.030","article-title":"Phosphorylation by JNK switches BRD4 functions","volume":"84","author":"Devaiah","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2026.117062_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2023.03.051","article-title":"Oleic acid stimulates cell proliferation and BRD4-L-MYC-dependent glucose transporter transcription through PPAR\u03b1 activation in ovarian cancer cells","volume":"657","author":"Kado","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117062_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153345","article-title":"ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis","volume":"219","author":"Dou","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA Signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0130","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.7150\/ijbs.104598","article-title":"TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis","volume":"21","author":"Yin","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.718","article-title":"BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.intimp.2026.117062_bb0145","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202307002","article-title":"m6Am methyltransferase PCIF1 negatively regulates ciliation by inhibiting BICD2 expression","volume":"223","author":"Xie","year":"2024","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117062_bb0150","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1093\/nar\/gkab252","article-title":"Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2\/4-PFKP during tumorigenesis of advanced prostate cancer","volume":"49","author":"Xu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117062_bb0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.omtn.2020.09.016","article-title":"circNR3C1 suppresses bladder cancer progression through acting as an endogenous blocker of BRD4\/C-myc complex","volume":"22","author":"Xie","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.intimp.2026.117062_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217156","article-title":"Glycolysis, the sweet appetite of the tumor microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.117062_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-022-00303-z","article-title":"Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma","volume":"11","author":"Oudaert","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41421-022-00395-1","article-title":"m(6)Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation","volume":"8","author":"Zhuo","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.intimp.2026.117062_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.753393","article-title":"A pan-cancer analysis of the oncogenic and immunogenic role of m6Am methyltransferase PCIF1","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12934-025-02701-4","article-title":"Introduction of human m(6)Am methyltransferase PCIF1 facilitates the biosynthesis of terpenoids in Saccharomyces cerevisiae","volume":"24","author":"Wang","year":"2025","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0190","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1038\/s41598-023-35793-2","article-title":"A pan-cancer analysis of the role of USP5 in human cancers","volume":"13","author":"Yan","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12935-025-03802-1","article-title":"SP1 promotes triple-negative breast cancer progression by targeting USP5","volume":"25","author":"Wu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.117062_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216875","article-title":"E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability","volume":"593","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.intimp.2026.117062_bb0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2016.04.135","article-title":"Smurf1 represses TNF-\u03b1 production through ubiquitination and destabilization of USP5","volume":"474","author":"Qian","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.117062_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.450","article-title":"Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.intimp.2026.117062_bb0215","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1182\/blood-2015-07-658203","article-title":"The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-024-01767-z","article-title":"PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression","volume":"26","author":"Peng","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.117062_bb0225","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41419-021-04356-6","article-title":"USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1","volume":"12","author":"Pan","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.intimp.2026.117062_bb0230","first-page":"525","article-title":"CircKCNQ5 controls proliferation, migration, invasion, apoptosis, and glycolysis of multiple myeloma cells by modulating miR-335-5p\/BRD4 axis","volume":"38","author":"Li","year":"2023","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.intimp.2026.117062_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2018.08.014","article-title":"PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma","volume":"104","author":"Fan","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117062_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112034","article-title":"BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer","volume":"392","author":"Jing","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117062_bb0245","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11060-024-04889-8","article-title":"BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression","volume":"171","author":"Liu","year":"2025","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cas.15190","article-title":"CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer","volume":"113","author":"Niu","year":"2022","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117062_bb0255","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/jcb.29420","article-title":"Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma","volume":"121","author":"Zhao","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2026.117062_bb0260","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","article-title":"PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect","volume":"9","author":"Gupta","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117062_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119145","article-title":"Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2","volume":"339","author":"Song","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117062_bb0270","article-title":"Bafetinib suppresses the transcription of PD-L1 through c-Myc in lung cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117062_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13123034","article-title":"Soluble programmed death ligand-1 (sPD-L1): a pool of circulating proteins implicated in health and diseases","volume":"13","author":"Bailly","year":"2021","journal-title":"Cancers"},{"issue":"7718","key":"10.1016\/j.intimp.2026.117062_bb0280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2026.117062_bb0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00262-024-03785-4","article-title":"The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of \u03b1CD3\u00d7\u03b1PD-L1 bispecific antibody-armed T cells","volume":"73","author":"Cho","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2026.117062_bb0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2026.117062_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","article-title":"Exosomal PD-L1: roles in tumor progression and immunotherapy","volume":"6","author":"Morrissey","year":"2020","journal-title":"Trends Cancer"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2026.117449","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000}},{"DOI":"10.1016\/j.intimp.2026.117449","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:00:00Z","timestamp":1794700800000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:47:39Z","timestamp":1786322859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"alternative-id":["S1567576926009082"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117062","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCIF1-mediated m6Am modification activates USP5\/BRD4 axis to promote glycolysis-driven immunosuppression in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117062"}}